Madrigal Pharmaceuticals
MDGL
MDGL
116 hedge funds and large institutions have $1.01B invested in Madrigal Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 57 increasing their positions, 24 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
15% less capital invested
Capital invested by funds: $1.19B → $1.01B (-$179M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
57% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 28
Holders
116
Holding in Top 10
2
Calls
$30.2M
Puts
$35.1M
Top Buyers
| 1 | +$14.7M | |
| 2 | +$9.8M | |
| 3 | +$7.54M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.39M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$5.24M |
Top Sellers
| 1 | -$17.7M | |
| 2 | -$6.87M | |
| 3 | -$6.31M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$6.26M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$5.32M |